Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Degradation of Incretins and Modulation of Blood Glucose Levels by Periodontopathic Bacterial Dipeptidyl Peptidase 4.

Ohara-Nemoto Y, Nakasato M, Shimoyama Y, Baba TT, Kobayakawa T, Ono T, Yaegashi T, Kimura S, Nemoto TK.

Infect Immun. 2017 Aug 18;85(9). pii: e00277-17. doi: 10.1128/IAI.00277-17. Print 2017 Sep.

2.

Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis.

Mulvihill EE, Varin EM, Gladanac B, Campbell JE, Ussher JR, Baggio LL, Yusta B, Ayala J, Burmeister MA, Matthews D, Bang KWA, Ayala JE, Drucker DJ.

Cell Metab. 2017 Jan 10;25(1):152-165. doi: 10.1016/j.cmet.2016.10.007. Epub 2016 Nov 10.

3.

An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease.

Zhong J, Rao X, Rajagopalan S.

Atherosclerosis. 2013 Feb;226(2):305-14. doi: 10.1016/j.atherosclerosis.2012.09.012. Epub 2012 Sep 21. Review.

PMID:
23083681
4.
6.

A novel multi-epitope vaccine based on Dipeptidyl Peptidase 4 prevents streptozotocin-induced diabetes by producing anti-DPP4 antibody and immunomodulatory effect in C57BL/6J mice.

Li Z, Fang J, Jiao R, Wei X, Ma Y, Liu X, Cheng P, Li T.

Biomed Pharmacother. 2017 May;89:1467-1475. doi: 10.1016/j.biopha.2017.01.089. Epub 2017 Mar 31.

PMID:
28376584
7.

Incretin effect: GLP-1, GIP, DPP4.

Kazafeos K.

Diabetes Res Clin Pract. 2011 Aug;93 Suppl 1:S32-6. doi: 10.1016/S0168-8227(11)70011-0. Review.

PMID:
21864749
8.

DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity.

Böhm A, Wagner R, Machicao F, Holst JJ, Gallwitz B, Stefan N, Fritsche A, Häring HU, Staiger H.

PLoS One. 2017 Jul 27;12(7):e0181880. doi: 10.1371/journal.pone.0181880. eCollection 2017.

9.
10.

Distribution of dipeptidyl peptidase (DPP) 4, DPP5, DPP7 and DPP11 in human oral microbiota-potent biomarkers indicating presence of periodontopathic bacteria.

Ohara-Nemoto Y, Shimoyama Y, Nakasato M, Nishimata H, Ishikawa T, Sasaki M, Kimura S, Nemoto TK.

FEMS Microbiol Lett. 2018 Nov 1;365(22). doi: 10.1093/femsle/fny221.

PMID:
30203018
11.

Cord serum dipeptidyl-peptidase 4 activity in gestational diabetes.

Al-Aissa Z, Rosta K, Hadarits O, Harreiter J, Zóka A, Bancher-Todesca D, Patócs A, Kiss K, Sármán B, Pusztai P, Sziller I, Rigó J, Rácz K, Somogyi A, Kautzky-Willer A, Firneisz G.

Eur J Clin Invest. 2015 Feb;45(2):196-203. doi: 10.1111/eci.12397.

PMID:
25556541
13.

Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.

Klemann C, Wagner L, Stephan M, von Hörsten S.

Clin Exp Immunol. 2016 Jul;185(1):1-21. doi: 10.1111/cei.12781. Epub 2016 May 13. Review.

14.

Mechanisms underlying the rapid degradation and elimination of the incretin hormones GLP-1 and GIP.

Mentlein R.

Best Pract Res Clin Endocrinol Metab. 2009 Aug;23(4):443-52. doi: 10.1016/j.beem.2009.03.005. Review.

PMID:
19748062
15.

Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling.

Rea D, Van Elzen R, De Winter H, Van Goethem S, Landuyt B, Luyten W, Schoofs L, Van Der Veken P, Augustyns K, De Meester I, Fülöp V, Lambeir AM.

Eur J Med Chem. 2017 Oct 20;139:482-491. doi: 10.1016/j.ejmech.2017.08.024. Epub 2017 Aug 10.

PMID:
28826083
16.

Therapeutic potential of dipeptidyl peptidase-IV inhibitors in patients with diabetes mellitus.

Moore KB, Saudek CD.

Am J Ther. 2008 Sep-Oct;15(5):484-91. doi: 10.1097/MJT.0b013e3180ed42dc. Review.

PMID:
18806525
17.

Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4).

Thornberry NA, Gallwitz B.

Best Pract Res Clin Endocrinol Metab. 2009 Aug;23(4):479-86. doi: 10.1016/j.beem.2009.03.004.

PMID:
19748065
18.

[Incretin hormones in the treatment of type 2 diabetes. Part I: influence of insulinotropic gut-derived hormones (incretins) on glucose metabolism].

Matuszek B, Lenart-Lipińska M, Nowakowski A.

Endokrynol Pol. 2007 Nov-Dec;58(6):522-8. Review. Polish.

PMID:
18205109
19.

The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects.

Rhee NA, Østoft SH, Holst JJ, Deacon CF, Vilsbøll T, Knop FK.

Eur J Endocrinol. 2014 Sep;171(3):353-62. doi: 10.1530/EJE-14-0314. Epub 2014 Jun 16.

PMID:
24935932
20.

The role of incretins in glucose homeostasis and diabetes treatment.

Kim W, Egan JM.

Pharmacol Rev. 2008 Dec;60(4):470-512. doi: 10.1124/pr.108.000604. Epub 2008 Dec 12. Review.

Supplemental Content

Support Center